222 related articles for article (PubMed ID: 23900236)
1. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in pediatric human sarcoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Oct; 43(4):1027-35. PubMed ID: 23900236
[TBL] [Abstract][Full Text] [Related]
2. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Jul; 43(1):39-49. PubMed ID: 23661254
[TBL] [Abstract][Full Text] [Related]
3. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2012 Sep; 28(3):768-76. PubMed ID: 22736175
[TBL] [Abstract][Full Text] [Related]
4. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Jun; 42(6):1883-9. PubMed ID: 23563849
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of urokinase plasminogen activator and matrix metalloproteinases and up-regulation of their inhibitors by a novel nutrient mixture in human prostate cancer cell lines PC-3 and DU-145.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2011 Dec; 26(6):1407-13. PubMed ID: 21874261
[TBL] [Abstract][Full Text] [Related]
6. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2014 Aug; 45(2):887-94. PubMed ID: 24867464
[TBL] [Abstract][Full Text] [Related]
7. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human colorectal, pancreatic and hepatic carcinoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2015 Jul; 47(1):370-6. PubMed ID: 25997494
[TBL] [Abstract][Full Text] [Related]
8. Effect of a nutrient mixture on matrix metalloproteinase-9 dimers in various human cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Int J Oncol; 2014 Mar; 44(3):986-92. PubMed ID: 24378964
[TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Int J Oncol; 2014 Jan; 44(1):27-34. PubMed ID: 24190483
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
11. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
[TBL] [Abstract][Full Text] [Related]
12. Gelatinase and inhibitor expression in soft tissue sarcomas: lack of correlation with distant metastasis.
Maguire PD; Qi W; Lallemand R; Scully SP
Oncology; 2000 Aug; 59(2):139-44. PubMed ID: 10971173
[TBL] [Abstract][Full Text] [Related]
13. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
14. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract][Full Text] [Related]
15. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
16. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion.
Di Nezza LA; Misajon A; Zhang J; Jobling T; Quinn MA; Ostör AG; Nie G; Lopata A; Salamonsen LA
Cancer; 2002 Mar; 94(5):1466-75. PubMed ID: 11920503
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
[TBL] [Abstract][Full Text] [Related]
18. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
Liu Z; Ivanoff A; Klominek J
Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
[TBL] [Abstract][Full Text] [Related]
19. Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2017 Jun; 37(6):3681-3687. PubMed ID: 28440509
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2010 Sep; 24(3):747-57. PubMed ID: 20664983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
